The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Can anyone confirm my understanding that the 40% EBITA is if the DHSC Q1 dispute doesn’t get resolved as they’ll still have spent x amount of operating costs and products minus the payment. If they win the dispute it should be back up around 76-80%?
Porky, I agree. The market needs audited figures, that will give NCYT the foundations to move onwards and upwards. The entire DHSC revenue can’t be up for dispute, therefore x amount will be discounted which will at least provide some transparency.
As long as the cash hasn’t vanished it will give funds the facts they need to be able to start buying in. The PE, NAV, EBITA will actually start to show how undervalued this is rather than still displaying 12 month old data.
Whether we rise, stay flat or drop a little we will all at least understand where the company is at in its journey.
I sincerely hope the ODDO broker notes were the final nail in the coffin for the Bourse listing. I am hoping the GBP comment is a hint for the management realising being listed on the bourse will never allow the company to reach true potential. Therefore we will be delisting. The thing I don’t know is whether they can literally delist from the bourse then offer all those shares on the (UK) stock market in some weird half IPO?? Anyone know how it works?
https://www.google.co.uk/amp/s/amp.lbc.co.uk/news/what-will-life-be-like-after-july-19-whitehall-leak-reveals-plans-for-new-normal/
Interesting read. Shows yet again testing is here to stay.
A total of 806 people in England have been admitted to hospital with the Delta variant of Covid-19 as of 14 June, new figures show.
This is a rise of 423 on the previous week, according to the data from Public Health England.
Of the 806 hospitalisations:
527 (65%) people were unvaccinated
135 (17%) were more than 21 days after their first dose of vaccine
84 (10%) were more than 14 days after their second dose.
As of 14 June, there have been 73 deaths in England of people who were confirmed as having the Delta variant and who died within 28 days of a positive test.
Of the 73 deaths:
34 (47%) were unvaccinated
10 (14%) were more than 21 days after their first dose of vaccine
26 (36%) were more than 14 days after their second dose.
Urraca, how have revenues halved? The entire amount from the contract won’t be up for dispute. We know circa £150mil of services have been provided, the gov can just say thank you, we’ve used your products but now don’t want to pay.
There will be a portion, how much is I know that will be involved in the dispute. If that has been agreed x amount (the amount not in the dispute) will probably have been included in the audited results. Following Tuesday I expect we will know how much the dispute is for.
Your post has been reported. There’s only so low this can go with the cash in the bank. There’s also only 9 trading days left of this quarter, of which the LFT Antigen is due to be launched within. Furthermore results are due by the end of the month. Yes pretty poor situation atm, things can change in a few hours as they did last year, it’s not over until the fat lady sings.
Troublesome where did you see about innova EUA being extended?
I genuinely think we’ll be in a sh*t state within a month. The vaccines will prove to be about 60% effective, similar to the flu jab as you can’t bastardise results when it’s done in real life. They also expected protection to last 6-8 months.
The most vulnerable had their first jab in December, second in March. We are now 3 months after the second jab with T cells and antibodies declining all the time.
If you were to go with the 60% efficacy, that could be up to 4400 cases a day (not taking into account age groups) who could be prone to serious illness as of today.
I don’t agree with how GM has played this, hopefully he has something up his sleeve to explain the silence and reward shareholders. Either way revenue will be around for a long time which should transform into a suitable PE in the medium term transforming us to a MIDCAP.
Shearclass, completely agree.
Interesting about curevac. I also think as the real trial is ongoing for Pfizer and AZN now, they’ll prove to be approx 60% effective similar to the flu jab when compared over a broader age group.
Ah ok, the article referred to testing requirements still under discussion. It also refers to white list countries declared by the EU where double vaccinated pers can travel without testing or quarantine requirements.
I think / hope the day 2 / day 8 test will remain as they’re the ones for variants and data gathering.
Anyone have any thoughts on the telegraph article regarding fully vaccinated travel to green / amber countries, possibly with no testing requirements?
I think it’s absolute madness as up to 50% of each flight won’t transmit COVID. That still leaves 50% of every flight who could bring in new strains.